Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

Published : Oct-2019

No. of Pages : 513

order by fax Inquire before Buying request discount

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Bone Grafts and Substitutes Overview
3 Products under Development
3.1 Bone Grafts and Substitutes - Pipeline Products by Stage of Development
3.2 Bone Grafts and Substitutes - Pipeline Products by Segment
3.3 Bone Grafts and Substitutes - Pipeline Products by Territory
3.4 Bone Grafts and Substitutes - Pipeline Products by Regulatory Path
3.5 Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date
3.6 Bone Grafts and Substitutes - Ongoing Clinical Trials
4 Bone Grafts and Substitutes - Pipeline Products under Development by Companies
4.1 Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development
4.2 Bone Grafts and Substitutes - Pipeline Products by Stage of Development
5 Bone Grafts and Substitutes Companies and Product Overview
5.1 Adocia SAS Company Overview
5.2 Aesculap Biologics LLC Company Overview
5.3 Agenta Biotechnologies Inc (Inactive) Company Overview
5.4 Alphatec Holdings Inc Company Overview
5.5 Amend Surgical, Inc. Company Overview
5.6 Anika Therapeutics Inc Company Overview
5.7 Antibe Therapeutics Inc Company Overview
5.8 Aperion Biologics Corp Company Overview
5.9 Arthro Kinetics AG Company Overview
5.10 Aursos, Inc (Inactive) Company Overview
5.11 Baxter International Inc Company Overview
5.12 Berkeley Advanced Biomaterials Inc Company Overview
5.13 Bio2 Technologies Inc Company Overview
5.14 Bioactive Bone Substitutes Plc Company Overview
5.15 BioGend Therapeutics Co Ltd Company Overview
5.16 BiolMed Innovations Pvt Ltd Company Overview
5.17 Biomatlante SA Company Overview
5.18 Bioregeneration Technologies, Inc Company Overview
5.19 Biorez Inc Company Overview
5.20 Bio-Scaffold International Pte Ltd Company Overview
5.21 Bioventus LLC Company Overview
5.22 Bone Solutions Inc Company Overview
5.23 BoneGrafix, Inc. Company Overview
5.24 BoneSupport AB Company Overview
5.25 Bonus BioGroup Ltd Company Overview
5.26 Calcitec, Inc. Company Overview
5.27 Carmell Therapeutics Corp Company Overview
5.28 Case Western Reserve University Company Overview
5.29 CeraPedics Inc Company Overview
5.30 Citrics Biomedical, LLC (Inactive) Company Overview
5.31 Collagen Solutions Plc Company Overview
5.32 Collplant Biotechnologies Ltd Company Overview
5.33 ConMed Corp Company Overview
5.34 curasan AG Company Overview
5.35 Daewoong Pharmaceutical Co Ltd Company Overview
5.36 Dimension Inx LLC Company Overview
5.37 Drexel University Company Overview
5.38 DSM Biomedical BV Company Overview
5.39 Element Orthopedics Inc (Inactive) Company Overview
5.40 ElutInc Company Overview
5.41 Ember Therapeutics Inc (Inactive) Company Overview
5.42 EpiBone Inc Company Overview
5.43 Eskisehir Osmangazi University Company Overview
5.44 EternoGen Aesthetics LLC Company Overview
5.45 Exactech Inc Company Overview
5.46 Ferring Pharmaceuticals AS Company Overview
5.47 Gene Biotherapeutics Inc Company Overview
5.48 Graftoss Limited Company Overview
5.49 Graftys SA Company Overview
5.50 Hospital for Special Surgery Company Overview
5.51 Induce Biologics Inc. Company Overview
5.52 Innovoss Inc. (Inactive) Company Overview
5.53 IRCCS San Raffaele Hospital Company Overview
5.54 Isto Biologics Company Overview
5.55 Johns Hopkins University Company Overview
5.56 kasios sas Company Overview
5.57 King's College London Company Overview
5.58 Kuros Biosciences AG Company Overview
5.59 Kytogenics Pharmaceuticals Inc Company Overview
5.60 Lattice Biologics Ltd Company Overview
5.61 Locate Bio Ltd Company Overview
5.62 Maxigen Biotech Inc Company Overview
5.63 Medisse BV (Inactive) Company Overview
5.64 Medtronic plc Company Overview
5.65 Miromatrix Medical Inc Company Overview
5.66 N2 Biomedical Company Overview
5.67 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
5.68 National University of Science and Technology MiSiS Company Overview
5.69 NovaBone Products LLC Company Overview
5.70 Nutech Medical Inc Company Overview
5.71 Oligo Medic Inc Company Overview
5.72 Orthocell Ltd Company Overview
5.73 OrthoMedex LLC Company Overview
5.74 OrthoPediatrics Corp Company Overview
5.75 Orthosera GmbH Company Overview
5.76 Osiris Therapeutics Inc Company Overview
5.77 OssiFi, Inc. Company Overview
5.78 OsteoNovus, LLC Company Overview
5.79 PolyPid Ltd Company Overview
5.80 Polytechnic University of Catalonia Company Overview
5.81 Promimic AB Company Overview
5.82 ReCaPP Company Overview
5.83 RepRegen Ltd. (Inactive) Company Overview
5.84 Revivicor Inc Company Overview
5.85 RTI Surgical Inc Company Overview
5.86 Sanara MedTech Inc Company Overview
5.87 Scil Technology GmbH Company Overview
5.88 SeaSpine, Inc. Company Overview
5.89 SIRAKOSS Ltd Company Overview
5.90 Sofregen Medical Inc Company Overview
5.91 Soteira Inc Company Overview
5.92 SurgaColl Technologies Ltd Company Overview
5.93 T&R Biofab Co Ltd Company Overview
5.94 TBF Genie Tissulaire Company Overview
5.95 The Chinese University of Hong Kong Company Overview
5.96 Theragnostic Technologies Inc Company Overview
5.97 Tissue Regeneration Systems, Inc. Company Overview
5.98 Trinity College Dublin Company Overview
5.99 University of California San Diego Company Overview
5.100 University of Edinburgh Company Overview
5.101 University of Malaya Company Overview
5.102 University of Maryland Company Overview
5.103 University of Memphis Company Overview
5.104 University of Pecs Company Overview
5.105 University of South Florida Company Overview
5.106 Vanderbilt University Company Overview
5.107 Wayne State University Company Overview
5.108 Wright Medical Group NV Company Overview
5.109 Xtant Medical Holdings Inc Company Overview
6 Bone Grafts and Substitutes- Recent Developments
6.1 Sep 26, 2019: CollPlant reports second quarter 2019 financial results and provides business update
6.2 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
6.3 Sep 24, 2019: Kuros Biosciences announces full commercial launch of MagnetOs and exhibitor status at North American Spine Society 34th Annual Meeting
6.4 Sep 24, 2019: Bone Bank Allografts launches global sales force initiative
6.5 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors
6.6 Sep 19, 2019: Medicrea reports first half 2019 financial results
6.7 Sep 04, 2019: Biogennix Launches Agilon Bone Grafting Solution
6.8 Aug 30, 2019: Bone Therapeutics reports half year 2019 results
6.9 Aug 30, 2019: BBS Interim Report H1/2019
6.10 Aug 29, 2019: Lattice Biologics reports third quarter 2019 results
6.11 Aug 28, 2019: BONESUPPORT announces partnership with Academy Medical
6.12 Aug 28, 2019: Medtronic announces planned leadership succession
6.13 Aug 27, 2019: Alphatec announces favorable judgment in NuVasive v. Miles lawsuit
6.14 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly
6.15 Aug 21, 2019: BONESUPPORT HOLDING announces that the patient enrolment schedule for the ongoing FORTIFY study is extended
6.16 Aug 21, 2019: NuVasive: Departure of directors or certain officers
6.17 Aug 20, 2019: Kuros Biosciences reports results for first half 2019
6.18 Aug 20, 2019: Medtronic reports first quarter financial results for 2019
7.Appendix

List of Tables
Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 24
Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment 25
Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory 26
Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 27
Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 28
Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 29
Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 30
Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 33
Table 9: Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview 38
Table 10: BioChaperone BMP - Degenerative Disc Disease - Product Status 38
Table 11: BioChaperone BMP - Degenerative Disc Disease - Product Description 39
Table 12: Biochaperone BMP - Non-Union Fractures - Product Status 39
Table 13: Biochaperone BMP - Non-Union Fractures - Product Description 39
Table 14: BioChaperone BMP - Osteoporosis - Product Status 40
Table 15: BioChaperone BMP - Osteoporosis - Product Description 40
Table 16: Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 41
Table 17: NOVOCART DISC - Product Status 41
Table 18: NOVOCART DISC - Product Description 41
Table 19: Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
Table 20: B-247 Cranial Bone Graft Implant - Product Status 42
Table 21: B-247 Cranial Bone Graft Implant - Product Description 42
Table 22: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 23: Alphatec Neocore Osteoconductive Matrix - Product Status 43
Table 24: Alphatec Neocore Osteoconductive Matrix - Product Description 43
Table 25: Bonex - Product Status 44
Table 26: Bonex - Product Description 44
Table 27: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 28: Biomimetic Bone - Product Status 45
Table 29: Biomimetic Bone - Product Description 45
Table 30: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 31: Hyalobone - Product Status 46
Table 32: Hyalobone - Product Description 46
Table 33: Hyalofast - Product Status 47
Table 34: Hyalofast - Product Description 47
Table 35: Hyalograft C Autograft - Product Status 47
Table 36: Hyalograft C Autograft - Product Description 48
Table 37: Anika Therapeutics Inc - Ongoing Clinical Trials Overview 49
Table 38: Hyalofast - A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast with BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control 50
Table 39: Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 40: CGX-227 - Product Status 51
Table 41: CGX-227 - Product Description 51
Table 42: CGX-443 - Product Status 52
Table 43: CGX-443 - Product Description 52
Table 44: Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 53
Table 45: Z-Fix - Product Status 53
Table 46: Z-Fix - Product Description 53
Table 47: Z-Meniscus - Product Status 54
Table 48: Z-Meniscus - Product Description 54
Table 49: Z-Patch - Product Status 54
Table 50: Z-Patch - Product Description 55
Table 51: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 56
Table 52: CaReS plus - Product Status 56
Table 53: CaReS plus - Product Description 56
Table 54: Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
Table 55: AUR-84 Resorbable Implant - Product Status 57
Table 56: AUR-84 Resorbable Implant - Product Description 57
Table 57: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 58: Synthetic Bone Graft - Spinal - Product Status 58
Table 59: Synthetic Bone Graft - Spinal - Product Description 58
Table 60: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 61: CPA Ceramics - Product Status 59
Table 62: CPA Ceramics - Product Description 59
Table 63: HAP Ceramics - Product Status 60
Table 64: HAP Ceramics - Product Description 60
Table 65: Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 66: Vitrium - Hammertoe Correction - Product Status 61
Table 67: Vitrium - Hammertoe Correction - Product Description 61
Table 68: Vitrium - Radial Osteotomy - Product Status 62
Table 69: Vitrium - Radial Osteotomy - Product Description 62
Table 70: Vitrium - Wrist Fracture Revision - Product Status 62
Table 71: Vitrium - Wrist Fracture Revision - Product Description 63
Table 72: Bioactive Bone Substitutes Plc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 73: ARTEBONE - Product Status 64
Table 74: ARTEBONE - Product Description 64
Table 75: Bone Graft Substitute - Blocks - Product Status 65
Table 76: Bone Graft Substitute - Blocks - Product Description 65
Table 77: Bone Graft Substitute - Granules - Product Status 65
Table 78: Bone Graft Substitute - Granules - Product Description 66
Table 79: BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
Table 80: OIF - Non-Union Bone Fracture - Product Status 67

List of Figures
Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 24
Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment 25
Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory 26
Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 27
Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 28
Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 29

Filed in: Medical Device, Orthopedic Devices

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027